Summary
According to APO Research, The global Drug-Device Combination Products market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drug-Device Combination Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drug-Device Combination Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drug-Device Combination Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drug-Device Combination Products is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim and Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Drug-Device Combination Products, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug-Device Combination Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug-Device Combination Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug-Device Combination Products revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drug-Device Combination Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drug-Device Combination Products revenue, projected growth trends, production technology, application and end-user industry.
Drug-Device Combination Products segment by Company
GSK
Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic
Mylan
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
Drug-Device Combination Products segment by Type
Drug-Coated Device
Prefilled Drug Delivery Systems
Nebulizer and Inhaler
Transdermal Delivery System
Others
Drug-Device Combination Products segment by Application
Hospital andClinic
Retail Pharmacies
Other
Drug-Device Combination Products segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Device Combination Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug-Device Combination Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Device Combination Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Drug-Device Combination Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Drug-Device Combination Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-Device Combination Products revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Drug-Device Combination Products Market by Type
1.2.1 Global Drug-Device Combination Products Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Nebulizer and Inhaler
1.2.5 Transdermal Delivery System
1.2.6 Others
1.3 Drug-Device Combination Products Market by Application
1.3.1 Global Drug-Device Combination Products Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital andClinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Drug-Device Combination Products Market Dynamics
2.1 Drug-Device Combination Products Industry Trends
2.2 Drug-Device Combination Products Industry Drivers
2.3 Drug-Device Combination Products Industry Opportunities and Challenges
2.4 Drug-Device Combination Products Industry Restraints
3 Global Growth Perspective
3.1 Global Drug-Device Combination Products Market Perspective (2019-2030)
3.2 Global Drug-Device Combination Products Growth Trends by Region
3.2.1 Global Drug-Device Combination Products Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Drug-Device Combination Products Market Size by Region (2019-2024)
3.2.3 Global Drug-Device Combination Products Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Drug-Device Combination Products Revenue by Players
4.1.1 Global Drug-Device Combination Products Revenue by Players (2019-2024)
4.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2019-2024)
4.1.3 Global Drug-Device Combination Products Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Drug-Device Combination Products Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Drug-Device Combination Products Key Players Headquarters & Area Served
4.4 Global Drug-Device Combination Products Players, Product Type & Application
4.5 Global Drug-Device Combination Products Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Drug-Device Combination Products Market CR5 and HHI
4.6.2 Global Top 5 and 10 Drug-Device Combination Products Players Market Share by Revenue in 2023
4.6.3 2023 Drug-Device Combination Products Tier 1, Tier 2, and Tier 3
5 Drug-Device Combination Products Market Size by Type
5.1 Global Drug-Device Combination Products Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Drug-Device Combination Products Revenue by Type (2019-2030)
5.3 Global Drug-Device Combination Products Revenue Market Share by Type (2019-2030)
6 Drug-Device Combination Products Market Size by Application
6.1 Global Drug-Device Combination Products Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Drug-Device Combination Products Revenue by Application (2019-2030)
6.3 Global Drug-Device Combination Products Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.1.4 GSK Drug-Device Combination Products Product Portfolio
7.1.5 GSK Recent Developments
7.2 Novo Nordisk
7.2.1 Novo Nordisk Comapny Information
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.2.4 Novo Nordisk Drug-Device Combination Products Product Portfolio
7.2.5 Novo Nordisk Recent Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Comapny Information
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.3.4 Eli Lilly Drug-Device Combination Products Product Portfolio
7.3.5 Eli Lilly Recent Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Comapny Information
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.4.4 AstraZeneca Drug-Device Combination Products Product Portfolio
7.4.5 AstraZeneca Recent Developments
7.5 Sanofi
7.5.1 Sanofi Comapny Information
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi Drug-Device Combination Products Product Portfolio
7.5.5 Sanofi Recent Developments
7.6 Boston Scientific
7.6.1 Boston Scientific Comapny Information
7.6.2 Boston Scientific Business Overview
7.6.3 Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.6.4 Boston Scientific Drug-Device Combination Products Product Portfolio
7.6.5 Boston Scientific Recent Developments
7.7 Abbott
7.7.1 Abbott Comapny Information
7.7.2 Abbott Business Overview
7.7.3 Abbott Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.7.4 Abbott Drug-Device Combination Products Product Portfolio
7.7.5 Abbott Recent Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Comapny Information
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.8.4 Boehringer Ingelheim Drug-Device Combination Products Product Portfolio
7.8.5 Boehringer Ingelheim Recent Developments
7.9 Medtronic
7.9.1 Medtronic Comapny Information
7.9.2 Medtronic Business Overview
7.9.3 Medtronic Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.9.4 Medtronic Drug-Device Combination Products Product Portfolio
7.9.5 Medtronic Recent Developments
7.10 Mylan
7.10.1 Mylan Comapny Information
7.10.2 Mylan Business Overview
7.10.3 Mylan Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.10.4 Mylan Drug-Device Combination Products Product Portfolio
7.10.5 Mylan Recent Developments
7.11 3M
7.11.1 3M Comapny Information
7.11.2 3M Business Overview
7.11.3 3M Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.11.4 3M Drug-Device Combination Products Product Portfolio
7.11.5 3M Recent Developments
7.12 Hisamitsu
7.12.1 Hisamitsu Comapny Information
7.12.2 Hisamitsu Business Overview
7.12.3 Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.12.4 Hisamitsu Drug-Device Combination Products Product Portfolio
7.12.5 Hisamitsu Recent Developments
7.13 Smith & Nephew
7.13.1 Smith & Nephew Comapny Information
7.13.2 Smith & Nephew Business Overview
7.13.3 Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.13.4 Smith & Nephew Drug-Device Combination Products Product Portfolio
7.13.5 Smith & Nephew Recent Developments
7.14 Molnlycke
7.14.1 Molnlycke Comapny Information
7.14.2 Molnlycke Business Overview
7.14.3 Molnlycke Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.14.4 Molnlycke Drug-Device Combination Products Product Portfolio
7.14.5 Molnlycke Recent Developments
7.15 Teleflex
7.15.1 Teleflex Comapny Information
7.15.2 Teleflex Business Overview
7.15.3 Teleflex Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.15.4 Teleflex Drug-Device Combination Products Product Portfolio
7.15.5 Teleflex Recent Developments
7.16 BD
7.16.1 BD Comapny Information
7.16.2 BD Business Overview
7.16.3 BD Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.16.4 BD Drug-Device Combination Products Product Portfolio
7.16.5 BD Recent Developments
7.17 Lepu Medical
7.17.1 Lepu Medical Comapny Information
7.17.2 Lepu Medical Business Overview
7.17.3 Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.17.4 Lepu Medical Drug-Device Combination Products Product Portfolio
7.17.5 Lepu Medical Recent Developments
7.18 MicroPort
7.18.1 MicroPort Comapny Information
7.18.2 MicroPort Business Overview
7.18.3 MicroPort Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.18.4 MicroPort Drug-Device Combination Products Product Portfolio
7.18.5 MicroPort Recent Developments
7.19 Terumo
7.19.1 Terumo Comapny Information
7.19.2 Terumo Business Overview
7.19.3 Terumo Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.19.4 Terumo Drug-Device Combination Products Product Portfolio
7.19.5 Terumo Recent Developments
7.20 B. Braun
7.20.1 B. Braun Comapny Information
7.20.2 B. Braun Business Overview
7.20.3 B. Braun Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.20.4 B. Braun Drug-Device Combination Products Product Portfolio
7.20.5 B. Braun Recent Developments
7.21 Antares Pharma
7.21.1 Antares Pharma Comapny Information
7.21.2 Antares Pharma Business Overview
7.21.3 Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (2019-2024)
7.21.4 Antares Pharma Drug-Device Combination Products Product Portfolio
7.21.5 Antares Pharma Recent Developments
8 North America
8.1 North America Drug-Device Combination Products Revenue (2019-2030)
8.2 North America Drug-Device Combination Products Revenue by Type (2019-2030)
8.2.1 North America Drug-Device Combination Products Revenue by Type (2019-2024)
8.2.2 North America Drug-Device Combination Products Revenue by Type (2025-2030)
8.3 North America Drug-Device Combination Products Revenue Share by Type (2019-2030)
8.4 North America Drug-Device Combination Products Revenue by Application (2019-2030)
8.4.1 North America Drug-Device Combination Products Revenue by Application (2019-2024)
8.4.2 North America Drug-Device Combination Products Revenue by Application (2025-2030)
8.5 North America Drug-Device Combination Products Revenue Share by Application (2019-2030)
8.6 North America Drug-Device Combination Products Revenue by Country
8.6.1 North America Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Drug-Device Combination Products Revenue by Country (2019-2024)
8.6.3 North America Drug-Device Combination Products Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Drug-Device Combination Products Revenue (2019-2030)
9.2 Europe Drug-Device Combination Products Revenue by Type (2019-2030)
9.2.1 Europe Drug-Device Combination Products Revenue by Type (2019-2024)
9.2.2 Europe Drug-Device Combination Products Revenue by Type (2025-2030)
9.3 Europe Drug-Device Combination Products Revenue Share by Type (2019-2030)
9.4 Europe Drug-Device Combination Products Revenue by Application (2019-2030)
9.4.1 Europe Drug-Device Combination Products Revenue by Application (2019-2024)
9.4.2 Europe Drug-Device Combination Products Revenue by Application (2025-2030)
9.5 Europe Drug-Device Combination Products Revenue Share by Application (2019-2030)
9.6 Europe Drug-Device Combination Products Revenue by Country
9.6.1 Europe Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Drug-Device Combination Products Revenue by Country (2019-2024)
9.6.3 Europe Drug-Device Combination Products Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Drug-Device Combination Products Revenue (2019-2030)
10.2 China Drug-Device Combination Products Revenue by Type (2019-2030)
10.2.1 China Drug-Device Combination Products Revenue by Type (2019-2024)
10.2.2 China Drug-Device Combination Products Revenue by Type (2025-2030)
10.3 China Drug-Device Combination Products Revenue Share by Type (2019-2030)
10.4 China Drug-Device Combination Products Revenue by Application (2019-2030)
10.4.1 China Drug-Device Combination Products Revenue by Application (2019-2024)
10.4.2 China Drug-Device Combination Products Revenue by Application (2025-2030)
10.5 China Drug-Device Combination Products Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Drug-Device Combination Products Revenue (2019-2030)
11.2 Asia Drug-Device Combination Products Revenue by Type (2019-2030)
11.2.1 Asia Drug-Device Combination Products Revenue by Type (2019-2024)
11.2.2 Asia Drug-Device Combination Products Revenue by Type (2025-2030)
11.3 Asia Drug-Device Combination Products Revenue Share by Type (2019-2030)
11.4 Asia Drug-Device Combination Products Revenue by Application (2019-2030)
11.4.1 Asia Drug-Device Combination Products Revenue by Application (2019-2024)
11.4.2 Asia Drug-Device Combination Products Revenue by Application (2025-2030)
11.5 Asia Drug-Device Combination Products Revenue Share by Application (2019-2030)
11.6 Asia Drug-Device Combination Products Revenue by Country
11.6.1 Asia Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Drug-Device Combination Products Revenue by Country (2019-2024)
11.6.3 Asia Drug-Device Combination Products Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Drug-Device Combination Products Revenue (2019-2030)
12.2 MEALA Drug-Device Combination Products Revenue by Type (2019-2030)
12.2.1 MEALA Drug-Device Combination Products Revenue by Type (2019-2024)
12.2.2 MEALA Drug-Device Combination Products Revenue by Type (2025-2030)
12.3 MEALA Drug-Device Combination Products Revenue Share by Type (2019-2030)
12.4 MEALA Drug-Device Combination Products Revenue by Application (2019-2030)
12.4.1 MEALA Drug-Device Combination Products Revenue by Application (2019-2024)
12.4.2 MEALA Drug-Device Combination Products Revenue by Application (2025-2030)
12.5 MEALA Drug-Device Combination Products Revenue Share by Application (2019-2030)
12.6 MEALA Drug-Device Combination Products Revenue by Country
12.6.1 MEALA Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Drug-Device Combination Products Revenue by Country (2019-2024)
12.6.3 MEALA Drug-Device Combination Products Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Drug-Coated Device Major Manufacturers
Table 2. Prefilled Drug Delivery Systems Major Manufacturers
Table 3. Nebulizer and Inhaler Major Manufacturers
Table 4. Transdermal Delivery System Major Manufacturers
Table 5. Others Major Manufacturers
Table 6. Global Drug-Device Combination Products Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Hospital andClinic Major Manufacturers
Table 8. Retail Pharmacies Major Manufacturers
Table 9. Other Major Manufacturers
Table 10. Drug-Device Combination Products Industry Trends
Table 11. Drug-Device Combination Products Industry Drivers
Table 12. Drug-Device Combination Products Industry Opportunities and Challenges
Table 13. Drug-Device Combination Products Industry Restraints
Table 14. Global Drug-Device Combination Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 15. Global Drug-Device Combination Products Market Size by Region (2019-2024) & (US$ Million)
Table 16. Global Drug-Device Combination Products Market Share by Region (2019-2024)
Table 17. Global Drug-Device Combination Products Market Size by Region (2025-2030) & (US$ Million)
Table 18. Global Drug-Device Combination Products Market Share by Region (2025-2030)
Table 19. Global Drug-Device Combination Products Revenue by Players (US$ Million) & (2019-2024)
Table 20. Global Drug-Device Combination Products Revenue Market Share by Players (2019-2024)
Table 21. Global Drug-Device Combination Products Key Players Ranking, 2022 VS 2023 VS 2024
Table 22. Global Drug-Device Combination Products Key Players Headquarters & Area Served
Table 23. Global Drug-Device Combination Products Players, Product Type & Application
Table 24. Global Drug-Device Combination Products Players Commercialization Time
Table 25. Global Players Market Concentration Ratio (CR5 and HHI)
Table 26. Global Drug-Device Combination Products by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 27. Global Drug-Device Combination Products Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Drug-Device Combination Products Revenue by Type (2019-2024) & (US$ Million)
Table 29. Global Drug-Device Combination Products Revenue by Type (2025-2030) & (US$ Million)
Table 30. Global Drug-Device Combination Products Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 31. Global Drug-Device Combination Products Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 32. Global Drug-Device Combination Products Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Drug-Device Combination Products Revenue by Application (2019-2024) & (US$ Million)
Table 34. Global Drug-Device Combination Products Revenue by Application (2025-2030) & (US$ Million)
Table 35. Global Drug-Device Combination Products Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 36. Global Drug-Device Combination Products Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 37. GSK Company Information
Table 38. GSK Business Overview
Table 39. GSK Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 40. GSK Drug-Device Combination Products Product Portfolio
Table 41. GSK Recent Development
Table 42. Novo Nordisk Company Information
Table 43. Novo Nordisk Business Overview
Table 44. Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 45. Novo Nordisk Drug-Device Combination Products Product Portfolio
Table 46. Novo Nordisk Recent Development
Table 47. Eli Lilly Company Information
Table 48. Eli Lilly Business Overview
Table 49. Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 50. Eli Lilly Drug-Device Combination Products Product Portfolio
Table 51. Eli Lilly Recent Development
Table 52. AstraZeneca Company Information
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 55. AstraZeneca Drug-Device Combination Products Product Portfolio
Table 56. AstraZeneca Recent Development
Table 57. Sanofi Company Information
Table 58. Sanofi Business Overview
Table 59. Sanofi Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 60. Sanofi Drug-Device Combination Products Product Portfolio
Table 61. Sanofi Recent Development
Table 62. Boston Scientific Company Information
Table 63. Boston Scientific Business Overview
Table 64. Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 65. Boston Scientific Drug-Device Combination Products Product Portfolio
Table 66. Boston Scientific Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Business Overview
Table 69. Abbott Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 70. Abbott Drug-Device Combination Products Product Portfolio
Table 71. Abbott Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 75. Boehringer Ingelheim Drug-Device Combination Products Product Portfolio
Table 76. Boehringer Ingelheim Recent Development
Table 77. Medtronic Company Information
Table 78. Medtronic Business Overview
Table 79. Medtronic Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 80. Medtronic Drug-Device Combination Products Product Portfolio
Table 81. Medtronic Recent Development
Table 82. Mylan Company Information
Table 83. Mylan Business Overview
Table 84. Mylan Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 85. Mylan Drug-Device Combination Products Product Portfolio
Table 86. Mylan Recent Development
Table 87. 3M Company Information
Table 88. 3M Business Overview
Table 89. 3M Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. 3M Drug-Device Combination Products Product Portfolio
Table 91. 3M Recent Development
Table 92. Hisamitsu Company Information
Table 93. Hisamitsu Business Overview
Table 94. Hisamitsu Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Hisamitsu Drug-Device Combination Products Product Portfolio
Table 96. Hisamitsu Recent Development
Table 97. Smith & Nephew Company Information
Table 98. Smith & Nephew Business Overview
Table 99. Smith & Nephew Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Smith & Nephew Drug-Device Combination Products Product Portfolio
Table 101. Smith & Nephew Recent Development
Table 102. Molnlycke Company Information
Table 103. Molnlycke Business Overview
Table 104. Molnlycke Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Molnlycke Drug-Device Combination Products Product Portfolio
Table 106. Molnlycke Recent Development
Table 107. Teleflex Company Information
Table 108. Teleflex Business Overview
Table 109. Teleflex Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Teleflex Drug-Device Combination Products Product Portfolio
Table 111. Teleflex Recent Development
Table 112. BD Company Information
Table 113. BD Business Overview
Table 114. BD Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. BD Drug-Device Combination Products Product Portfolio
Table 116. BD Recent Development
Table 117. Lepu Medical Company Information
Table 118. Lepu Medical Business Overview
Table 119. Lepu Medical Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Lepu Medical Drug-Device Combination Products Product Portfolio
Table 121. Lepu Medical Recent Development
Table 122. MicroPort Company Information
Table 123. MicroPort Business Overview
Table 124. MicroPort Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. MicroPort Drug-Device Combination Products Product Portfolio
Table 126. MicroPort Recent Development
Table 127. Terumo Company Information
Table 128. Terumo Business Overview
Table 129. Terumo Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Terumo Drug-Device Combination Products Product Portfolio
Table 131. Terumo Recent Development
Table 132. B. Braun Company Information
Table 133. B. Braun Business Overview
Table 134. B. Braun Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. B. Braun Drug-Device Combination Products Product Portfolio
Table 136. B. Braun Recent Development
Table 137. Antares Pharma Company Information
Table 138. Antares Pharma Business Overview
Table 139. Antares Pharma Drug-Device Combination Products Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Antares Pharma Drug-Device Combination Products Product Portfolio
Table 141. Antares Pharma Recent Development
Table 142. North America Drug-Device Combination Products Revenue by Type (2019-2024) & (US$ Million)
Table 143. North America Drug-Device Combination Products Revenue by Application (2019-2024) & (US$ Million)
Table 144. North America Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 145. North America Drug-Device Combination Products Revenue by Country (2019-2024) & (US$ Million)
Table 146. North America Drug-Device Combination Products Revenue by Country (2025-2030) & (US$ Million)
Table 147. Europe Drug-Device Combination Products Revenue by Type (2019-2024) & (US$ Million)
Table 148. Europe Drug-Device Combination Products Revenue by Application (2019-2024) & (US$ Million)
Table 149. Europe Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 150. Europe Drug-Device Combination Products Revenue by Country (2019-2024) & (US$ Million)
Table 151. Europe Drug-Device Combination Products Revenue by Country (2025-2030) & (US$ Million)
Table 152. China Drug-Device Combination Products Revenue by Type (2019-2024) & (US$ Million)
Table 153. China Drug-Device Combination Products Revenue by Application (2019-2024) & (US$ Million)
Table 154. Asia Drug-Device Combination Products Revenue by Type (2019-2024) & (US$ Million)
Table 155. Asia Drug-Device Combination Products Revenue by Application (2019-2024) & (US$ Million)
Table 156. Asia Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 157. Asia Drug-Device Combination Products Revenue by Country (2019-2024) & (US$ Million)
Table 158. Asia Drug-Device Combination Products Revenue by Country (2025-2030) & (US$ Million)
Table 159. MEALA Drug-Device Combination Products Revenue by Type (2019-2024) & (US$ Million)
Table 160. MEALA Drug-Device Combination Products Revenue by Application (2019-2024) & (US$ Million)
Table 161. MEALA Drug-Device Combination Products Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 162. MEALA Drug-Device Combination Products Revenue by Country (2019-2024) & (US$ Million)
Table 163. MEALA Drug-Device Combination Products Revenue by Country (2025-2030) & (US$ Million)
Table 164. Research Programs/Design for This Report
Table 165. Authors List of This Report
Table 166. Secondary Sources
Table 167. Primary Sources
List of Figures
Figure 1. Drug-Device Combination Products Product Picture
Figure 2. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Drug-Device Combination Products Market Size Share 2019 VS 2023 VS 2030
Figure 4. Drug-Coated Device Picture
Figure 5. Prefilled Drug Delivery Systems Picture
Figure 6. Nebulizer and Inhaler Picture
Figure 7. Transdermal Delivery System Picture
Figure 8. Others Picture
Figure 9. Global Drug-Device Combination Products Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 10. Global Drug-Device Combination Products Market Size Share 2019 VS 2023 VS 2030
Figure 11. Hospital andClinic Picture
Figure 12. Retail Pharmacies Picture
Figure 13. Other Picture
Figure 14. Global Drug-Device Combination Products Market Size (US$ Million) & (2019-2030)
Figure 15. Global Drug-Device Combination Products Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Drug-Device Combination Products Market Share by Region: 2019 VS 2023 VS 2030
Figure 17. Global Drug-Device Combination Products Players Revenue Share Top 10 and Top 5 in 2023
Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Drug-Device Combination Products Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Drug-Device Combination Products Revenue Market Share 2019 VS 2023 VS 2030
Figure 21. Global Drug-Device Combination Products Revenue Market Share by Type (2019-2030)
Figure 22. Global Drug-Device Combination Products Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Drug-Device Combination Products Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 24. Global Drug-Device Combination Products Revenue Market Share by Application (2019-2030)
Figure 25. North America Drug-Device Combination Products Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Drug-Device Combination Products Revenue by Type (2025-2030) & (US$ Million)
Figure 27. North America Drug-Device Combination Products Revenue Share by Type (2019-2030)
Figure 28. North America Drug-Device Combination Products Revenue by Application (2025-2030) & (US$ Million)
Figure 29. North America Drug-Device Combination Products Revenue Share by Application (2019-2030)
Figure 30. North America Drug-Device Combination Products Revenue Share by Country (2019-2030)
Figure 31. United States Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Canada Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 33. Europe Drug-Device Combination Products Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 34. Europe Drug-Device Combination Products Revenue by Type (2025-2030) & (US$ Million)
Figure 35. Europe Drug-Device Combination Products Revenue Share by Type (2019-2030)
Figure 36. Europe Drug-Device Combination Products Revenue by Application (2025-2030) & (US$ Million)
Figure 37. Europe Drug-Device Combination Products Revenue Share by Application (2019-2030)
Figure 38. Europe Drug-Device Combination Products Revenue Share by Country (2019-2030)
Figure 39. Germany Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. France Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. U.K. Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Italy Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Russia Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. Nordic Countries Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. China Drug-Device Combination Products Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 46. China Drug-Device Combination Products Revenue by Type (2025-2030) & (US$ Million)
Figure 47. China Drug-Device Combination Products Revenue Share by Type (2019-2030)
Figure 48. China Drug-Device Combination Products Revenue by Application (2025-2030) & (US$ Million)
Figure 49. China Drug-Device Combination Products Revenue Share by Application (2019-2030)
Figure 50. Asia Drug-Device Combination Products Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 51. Asia Drug-Device Combination Products Revenue by Type (2025-2030) & (US$ Million)
Figure 52. Asia Drug-Device Combination Products Revenue Share by Type (2019-2030)
Figure 53. Asia Drug-Device Combination Products Revenue by Application (2025-2030) & (US$ Million)
Figure 54. Asia Drug-Device Combination Products Revenue Share by Application (2019-2030)
Figure 55. Asia Drug-Device Combination Products Revenue Share by Country (2019-2030)
Figure 56. Japan Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. South Korea Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. India Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Australia Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. China Taiwan Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. Southeast Asia Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. MEALA Drug-Device Combination Products Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 63. MEALA Drug-Device Combination Products Revenue by Type (2025-2030) & (US$ Million)
Figure 64. MEALA Drug-Device Combination Products Revenue Share by Type (2019-2030)
Figure 65. MEALA Drug-Device Combination Products Revenue by Application (2025-2030) & (US$ Million)
Figure 66. MEALA Drug-Device Combination Products Revenue Share by Application (2019-2030)
Figure 67. MEALA Drug-Device Combination Products Revenue Share by Country (2019-2030)
Figure 68. Mexico Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. South Korea Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Brazil Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Israel Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Argentina Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Colombia Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Turkey Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Saudi Arabia Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. UAE Drug-Device Combination Products Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Years Considered
Figure 78. Research Process
Figure 79. Key Executives Interviewed
